TargetMol Chemicals Inc | |
Galunisertib (LY2157299) is a TGF-β receptor type I (TGF-βRI) inhibitor (IC50=56 nM) that is selective. Galunisertib has antitumor activity and can be used in combination with PD-1 inhibitors. ![]() | |
Related Link: Click here to visit item owner's website (0 hit) | |
Target State: Illinois Target City : usa Last Update : May 28, 2025 7:10 AM Number of Views: 17 | Item Owner : hami Contact Email: Contact Phone: (None) |
Friendly reminder: Click here to read some tips. |